<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To investigate telomerase as a predictive marker of radiotherapy response in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Expression of the telomerase catalytic subunit hTERT was quantified with reverse transcription PCR in the radioresistant <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell line SW620 following exposure to 5Gy of radiation </plain></SENT>
<SENT sid="2" pm="."><plain>Additionally, 52 rectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases were pre-operatively treated with either the short (n = 19) or long (n = 33) course radiotherapy (SCR, LCR, respectively) regimes, before and after which their hTERT expressions were semi-quantified with immunohistochemistry (IHC) </plain></SENT>
<SENT sid="3" pm="."><plain>This was correlated with the histological <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> regression in the resected bowel, dichotomised into good and poor responses </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: SW620 cells expressed gradually increasing levels of hTERT after radiation </plain></SENT>
<SENT sid="5" pm="."><plain>hTERT IHC positivity of ≤75% <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells in pre-radiotherapied <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was the optimal negative cut-off level [sensitivity 63.2%, specificity 45.8%, area under curve (AUC) 0.5362] in predicting good <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> response </plain></SENT>
<SENT sid="6" pm="."><plain>As significantly more LCR cases showed good <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> response (p&lt;0.0001), the SCR cases were excluded and AUC re-analysed, which still remained low (0.5357) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: While our in vitro results suggest that hTERT up-regulation may contribute to radiation resistance of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, our in vivo results demonstrated poor ability of hTERT IHC in predicting histological <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> regression in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
</text></document>